Doctors Note Logo

Published on: 8/18/2026

The Science of Vitamin D Depletion: How Low Calcifediol Halts Bone Mineral Production

Vitamin D becomes calcifediol (25-hydroxyvitamin D) in the liver before the kidneys convert it into active calcitriol, so when calcifediol runs low the body cannot absorb enough calcium and phosphate from food to build hydroxyapatite, the mineral that hardens bone. As absorption falls, parathyroid hormone climbs and pulls calcium out of the skeleton, leaving newly formed bone soft and under-mineralized, which shows up as rickets in children and osteomalacia, bone pain, or muscle weakness in adults. Several factors influence how quickly this happens, including sun exposure, skin tone, age, body weight, kidney and liver function, malabsorption, and certain medications, and important thresholds and warning signs are explained below.

If aching bones, fatigue, or muscle weakness are part of your picture, guessing at the cause can delay treatment that is often simple once the underlying driver is identified. Take a free, instant, online symptom check to see which conditions may explain your symptoms and what step to take next.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

The Science of Vitamin D Depletion: How Low Calcifediol Halts Bone Mineral Production

Vitamin D plays a central role in keeping bones strong and healthy. When levels of calcifediol (25‐hydroxyvitamin D) drop too low, the body’s ability to mineralize bone weakens, leading to conditions like osteomalacia. Understanding why this happens, what causes Vitamin D deficiency, and how to prevent or treat it can help you protect your skeletal health.


How Vitamin D Becomes Active

  1. Skin synthesis and dietary intake

    • Ultraviolet B (UVB) rays convert 7‐dehydrocholesterol in skin into cholecalciferol (Vitamin D₃).
    • Foods such as fatty fish, fortified dairy, or supplements supply cholecalciferol (D₃) or ergocalciferol (D₂).
  2. Liver conversion to calcifediol

    • Cholecalciferol travels to the liver.
    • The enzyme 25-hydroxylase converts it into calcifediol (25-OH-D).
    • Serum calcifediol reflects total Vitamin D status.
  3. Kidney activation to calcitriol

    • Under control of parathyroid hormone (PTH), 1-alpha-hydroxylase in the kidney converts calcifediol into calcitriol (1,25-(OH)₂-D), the active hormone.
    • Calcitriol binds Vitamin D receptors in the gut and bone, increasing calcium absorption and bone mineralization.

Why Low Calcifediol Hurts Bone Mineral Production

Even if calcitriol levels remain normal for a time, depleted calcifediol undermines bone health:

  • Reduced substrate for calcitriol
    Without enough calcifediol, the kidneys lack raw material to make calcitriol. Over time, calcitriol levels fall, lowering intestinal calcium absorption.

  • Hypocalcemia and secondary hyperparathyroidism
    As calcium absorption drops, blood calcium dips. The parathyroid glands secrete more PTH to maintain calcium:

    • PTH increases bone resorption (breakdown) to release calcium.
    • Chronic PTH elevation disrupts normal bone remodeling.
  • Impaired mineralization (Osteomalacia)
    Bone matrix (osteoid) forms normally, but without adequate calcium and phosphate deposition, it remains soft. This is osteomalacia in adults, characterized by:

    • Diffuse bone pain and tenderness
    • Muscle weakness and difficulty walking
    • Increased fracture risk (particularly hips, ribs, wrists)

Vitamin D Deficiency and Osteomalacia: Common Causes

Understanding why calcifediol falls helps in both prevention and treatment. Key causes include:

  • Inadequate sun exposure

    • Living at high latitudes or indoors
    • Use of sunblock or clothing that blocks UVB
    • Seasonal variations (winter months)
  • Dietary insufficiency

    • Vegan or restrictive diets lacking fortified foods
    • Low intake of fatty fish, egg yolks, dairy
  • Malabsorption disorders

    • Celiac disease, Crohn’s disease, cystic fibrosis
    • Bariatric surgery reducing small‐intestinal surface
  • Liver disease

    • Chronic hepatitis or cirrhosis impairing 25-hydroxylation
  • Kidney disease

    • Reduced 1-alpha-hydroxylase activity limiting calcitriol production
  • Medications

    • Anti-seizure drugs (phenobarbital, phenytoin)
    • Glucocorticoids (long-term use)
    • Some weight-loss agents and antifungals
  • Aging and skin changes

    • Older adults have decreased skin capacity to synthesize Vitamin D
    • Renal function often declines with age

Signs and Diagnosis

Symptoms to Watch For

  • Deep, aching bone pain (hips, pelvis, spine)
  • Muscle weakness or cramps
  • Difficulty walking or climbing stairs
  • Frequent fractures with minimal trauma

Lab and Imaging Findings

  • Serum calcifediol (25-OH-D) below 20 ng/mL indicates deficiency
  • Elevated PTH (secondary hyperparathyroidism)
  • Low calcium and phosphate (may be mild)
  • X-rays showing Looser’s zones (pseudofractures) in long bones
  • Bone mineral density (DEXA) may show low bone mass

Prevention and Treatment Strategies

  1. Optimize Sun Exposure

    • Aim for 10–30 minutes of midday sun several times per week
    • Expose face, arms, legs without sunscreen (when safe)
  2. Dietary Sources and Fortification

    • Incorporate fatty fish (salmon, mackerel), egg yolks, fortified milk or plant milks
    • Check food labels for Vitamin D content
  3. Supplementation

    • Typical maintenance: 600–2,000 IU/day of Vitamin D₃ (individual needs vary)
    • Higher doses (up to 50,000 IU weekly) under medical supervision for deficiency
    • Recheck calcifediol levels after 3–6 months of therapy
  4. Address Underlying Disorders

    • Manage malabsorption (gluten-free diet, pancreatic enzyme replacement)
    • Optimize liver and kidney function
    • Review medications that interfere with Vitamin D metabolism
  5. Monitor Bone Health

    • Periodic serum calcifediol, calcium, phosphate, PTH tests
    • Bone density scans as recommended by your healthcare provider

When to Seek Further Evaluation

If you experience persistent bone pain, muscle weakness, or unexplained fractures, it’s important to get a professional assessment. You might start with a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/) to help guide your next steps. Always speak to a doctor about anything that could be life threatening or serious.


Key Takeaways

  • Calcifediol (25-OH-D) is the main storage form of Vitamin D and crucial for bone mineral production.
  • Low calcifediol leads to reduced calcitriol, poor calcium absorption, and secondary hyperparathyroidism.
  • Chronic deficiency causes osteomalacia—softening of bone—resulting in pain, weakness, and fractures.
  • Causes include poor sun exposure, diet, malabsorption, liver/kidney disease, certain medications, and aging.
  • Prevention and treatment focus on sensible sun exposure, diet, supplements, and correction of underlying issues.

Protect your bones by ensuring adequate Vitamin D levels. If you have symptoms or risk factors for deficiency, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/), and speak to a doctor for personalized advice.

(References)

  • * Wagman RB, Marcus R. Beyond bone mineral density-navigating the laboratory assessment of patients with osteoporosis. J Clin Endocrinol Metab. 2002 Oct;87(10):4429-30. doi: 10.1210/jc.2002-021310. PMID: 12364412.

  • * States LJ. Imaging of rachitic bone. Endocr Dev. 2003;6:80-92. doi: 10.1159/000072771. PMID: 12964427.

  • * del Campo MT, Aguado P. [Vitamin D: looking for optimum level]. Med Clin (Barc). 2006 Nov 4;127(17):651-2. doi: 10.1157/13094832. PMID: 17169282.

  • * Maricic M. Osteomalacia. Curr Osteoporos Rep. 2008 Dec;6(4):130-3. doi: 10.1007/s11914-008-0023-7. PMID: 19032922.

  • * Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011 Jan;86(1):50-60. doi: 10.4065/mcp.2010.0567. PMID: 21193656; PMCID: PMC3012634.

  • * Patton CM, Powell AP, Patel AA. Vitamin D in orthopaedics. J Am Acad Orthop Surg. 2012 Mar;20(3):123-9. doi: 10.5435/JAAOS-20-03-123. PMID: 22382284.

  • * Carpenter TO, Shaw NJ, Portale AA, Ward LM, Abrams SA, Pettifor JM. Rickets. Nat Rev Dis Primers. 2017 Dec 21;3:17101. doi: 10.1038/nrdp.2017.101. Epub 2017 Dec 21. PMID: 29265106.

  • * Narang RK, Reid I. Osteomalacia in subtropical Auckland. BMJ Case Rep. 2019 Jul 8;12(7). doi: 10.1136/bcr-2019-229657. Epub 2019 Jul 8. PMID: 31289164; PMCID: PMC6615813.

  • * Torregrosa JV, Ferreira AC, Cucchiari D, Ferreira A. Bone Mineral Disease After Kidney Transplantation. Calcif Tissue Int. 2021 Apr;108(4):551-560. doi: 10.1007/s00223-021-00837-0. Epub 2021 Mar 25. PMID: 33765230.

  • * Jannin A, Kerlan V, Desailloud R. Endocrinology of bone mineralization: An update. Ann Endocrinol (Paris). 2022 Feb;83(1):46-53. doi: 10.1016/j.ando.2021.12.001. Epub 2021 Dec 16. PMID: 34921812.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.